The Pennant Group (NASDAQ:PNTG) Earns “Overweight” Rating from Stephens

Stephens restated their overweight rating on shares of The Pennant Group (NASDAQ:PNTG) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $25.00 target price on the stock.

Other equities analysts have also issued research reports about the stock. Oppenheimer increased their target price on shares of The Pennant Group from $18.00 to $22.00 and gave the stock an outperform rating in a research report on Friday, March 1st. Royal Bank of Canada lifted their target price on shares of The Pennant Group from $21.00 to $26.00 and gave the company an outperform rating in a research report on Thursday, May 9th. Finally, Truist Financial lifted their target price on shares of The Pennant Group from $22.00 to $25.00 and gave the company a hold rating in a research report on Wednesday, May 15th.

The Pennant Group Stock Performance

Shares of PNTG stock opened at $22.52 on Thursday. The firm has a 50-day moving average of $22.20 and a 200-day moving average of $18.56. The company has a market cap of $676.64 million, a P/E ratio of 41.70, a P/E/G ratio of 2.33 and a beta of 2.02. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.16 and a quick ratio of 1.16. The Pennant Group has a one year low of $10.31 and a one year high of $24.09.

The Pennant Group (NASDAQ:PNTG) last posted its quarterly earnings data on Monday, May 6th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15. The business had revenue of $156.92 million during the quarter, compared to the consensus estimate of $146.01 million. The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. Equities research analysts forecast that The Pennant Group will post 0.73 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Covestor Ltd raised its stake in shares of The Pennant Group by 3,805.6% during the first quarter. Covestor Ltd now owns 1,406 shares of the company’s stock worth $28,000 after acquiring an additional 1,370 shares in the last quarter. Corton Capital Inc. increased its stake in shares of The Pennant Group by 21.6% in the third quarter. Corton Capital Inc. now owns 14,032 shares of the company’s stock worth $156,000 after buying an additional 2,497 shares during the period. AJOVista LLC purchased a new position in shares of The Pennant Group in the fourth quarter worth $35,000. DekaBank Deutsche Girozentrale purchased a new position in shares of The Pennant Group in the fourth quarter worth $52,000. Finally, Trexquant Investment LP increased its stake in shares of The Pennant Group by 20.8% in the third quarter. Trexquant Investment LP now owns 31,346 shares of the company’s stock worth $349,000 after buying an additional 5,400 shares during the period. 85.88% of the stock is owned by hedge funds and other institutional investors.

About The Pennant Group

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.